STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #518 by analyst upside · 2026-06-27
COYA
Coya Therapeutics, Inc.
Healthcare · Market Cap $129M · P/E 0x
ANALYST PRICE TARGET
+176.6%
implied upside to consensus target
Current Price $5.5
Consensus Target $15.21
Bull Target $18.0
Bear Target $12.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
7
Hold
0
Sell
0
52-Week Low $3.71
52-Week High $7.75
YTD Return -2.7%
FUNDAMENTALS
Market Cap $129M
P/E Ratio (TTM) N/A
Forward P/E -3.0x
EPS (TTM) $-1.15
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $8M
Profit Margin -266.1%
52-WEEK RANGE
52-Week Low $3.71
52-Week High $7.75
Current Price $5.5
Bear Target $12.0
Bull Target $18.0
● Now $5.5 ● Target $15.21
TRADING DATA
Avg Volume 167K
YTD Return -2.7%
Analyst Count 7
Consensus Buy
Upside to Target +176.6%
Last Updated 2026-06-27

ANALYST SUMMARY

Coya Therapeutics, Inc. (COYA) is currently trading at $5.5 with a Wall Street consensus price target of $15.21, implying potential upside of 176.6% over the next 12 months. 7 analysts currently cover COYA, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.0, while the most cautious has a target of $12.0.

COYA operates in the Healthcare sector with a market capitalisation of $129M. The stock is down 2.7% year-to-date and is currently trading near the lower end of its 52-week range of $3.71 – $7.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for COYA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Chardan Capital — Reiterated
Buy → Buy 2026-06-12 33% win rate (6 calls)
Roth Capital ● Initiated
Buy 2026-06-05 Building track record
D. Boral Capital — Reiterated
Buy → Buy 2026-04-10 32% win rate (25 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-03-23 31% win rate (48 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-03-19 32% win rate (25 calls)
Chardan Capital — Reiterated
Buy → Buy 2026-03-16 33% win rate (6 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-03-16 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-02-18 32% win rate (25 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
16/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →